Merck & Company (MRK-N) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$-1.01	$1.73	$4.93	$9.91
Number of Estimates	6	6	10	8
High Estimate	$1.55	$2.18	$5.23	$10.31
Low Estimate	$-1.63	$-0.20	$2.90	$9.73
Prior Year	$2.22	$2.13	$8.98	$4.93
Growth Rate Est. (year over year)	-145.50%	-18.78%	-45.10%	+101.01%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$2.04	$2.58	$2.13	$2.22
Estimate	$2.03	$2.36	$2.01	$2.15
Difference	+0.01	+0.22	+0.12	+0.07
Surprise	+0.49%	+9.32%	+5.97%	+3.26%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.07

3 Mths Ago27

4.18

2 Mths Ago28

4.24

1 Mth Ago29

4.29

Current28

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	27	28	29	28
	15 1	17 1	17 2	17 2
Holds	10	9	10	9
	1	1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility

It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says

Why did shares of GFL Environmental drop 10 per cent this week? Take our business and investing news quiz